AbbVie Employee Directory

With the Allergan acquisition, we are bringing together over 30 brands and leadership positions to expand and diversify our product portfolio. This allows us to have immediate scale and profitability to advance our innovative science pipeline that brings patients groundbreaking medicines across a wide spectrum of therapeutic need/critical therapeut... ic areas. We continue to build a sustainable company for the long term that provides profitable growth for shareholders, financial flexibility to invest and expand our reach to help address the needs of people and communities around the world. The new AbbVie will be a well-diversified leader in many important therapeutic categories, with both on-market and pipeline assets, and our financial strength will allow us to continue to invest in innovative science and continue to serve unmet medical needs of patients that rely upon us. I am proud of both organizations and look forward to the opportunities ahead. Richard A. Gonzalez, chairman and chief executive officer, AbbVie Learn how the acquisition of Allergan allows us to better serve patients today and invest in the medicines of the future. The link below will take you out of the AbbVie family of websites. Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie. The Internet site that you have requested may not be optimized to your screen size. Do you wish to leave this site? Recommended Offer for Allergan plc (Allergan) by AbbVie Inc. (AbbVie) (the Acquisition) by means of a scheme of arrangement under Irish law (the Scheme). You are attempting to enter the section of this website that is designated for the publication of documents and information in connection with the offer by AbbVie for Allergan announced on June 25, 2019 (the ...Read More